Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

4/11/2018, Wednesday

Media Contacts:
Kristy Marks
kristy.marks@bausch.com 
(908) 927-0683 

Teresa Panas
tpanas@biocommnetwork.com 
(973) 809-8590

BAUSCH + LOMB TO SHOWCASE LATEST INNOVATIONS, NEW SCIENTIFIC DATA DURING THE ANNUAL MEETING OF THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY

Wet Lab, Educational Programs Provide Opportunities for First-Hand Experience, Continued Learning

BRIDGEWATER, N.J., April 11, 2018 – Bausch + Lomb, a leading global eye health company, will showcase its latest innovations, including the enVista® MX60E intraocular lens (IOL) with StableFlex™ technology, as well as new scientific data during the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in Washington, D.C., April 13-17. Additionally, a wet lab at the company’s booth (#2242), as well as educational programs, will provide opportunities for surgeons to gain first-hand experience with, and learn more about, Bausch + Lomb technologies.

“Bausch + Lomb is committed to investing in, and delivering, new innovations designed to help surgeons operate more efficiently and effectively,” said Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb. “We look forward to sharing these innovations, as well as the new data demonstrating their clinical benefits, with those attending the meeting.”  

For the second consecutive year during ASCRS, surgeons can “test drive” Bausch + Lomb’s comprehensive offering of surgical solutions at the immersive wet lab experience in the company’s booth. The technologies featured will include the company’s latest next-generation platform for cataract and retina surgery, Stellaris Elite, the VICTUS® femtosecond laser for advanced cataract and corneal applications, and its broad selection of IOLs and delivery systems, including the new enVista® MX60E with StableFlex™ technology, as well as the Crystalens® AO and TRULIGN® Toric. 

For more information and to schedule an appointment in the wet lab visit: www.testdrivebausch.com.

In addition to the innovations featured in the wet lab, the Bausch + Lomb Storz® ophthalmic instrument portfolio for cataract and refractive surgery will be on display and available for purchase at the company’s booth. The LaserEdge® Plus disposable knives are the newest series of instruments added to the company’s comprehensive portfolio of Storz products. This new line of knives will feature single-handed operation safety guard handles, several new knife designs and a selection of disposable LRI knives. An assortment of these new knives will also be available for purchase at the booth.  

Scientific Podium Presentations and Posters
During the meeting, 21 podium presentations, e-posters and films will feature Bausch + Lomb’s surgical technologies. The full schedule includes:


Saturday, April 14

  • Sheppard, John. “Thirty-Six Month Clinical Experience with a Hydrophobic Acrylic IOL in Patients with Endothelial Compromise Undergoing Simultaneous Cataract Extraction and DSEK.” Saturday, April 14 at 4:15 p.m.; Level 1, Room 144C

  • Shultz, Mitchell C. “Analysis of Optical Aberrations and Depth of Focus Using a Ray-Tracing Analyzer in Patients with Zero Spherical Aberration IOLs.” Saturday, April 14 at 1:07 p.m.; Level 1, Room 143B


Sunday, April 15 

  • Koch, Douglas D. “Evaluation of a New Phacoemulsification Infusion System.” Sunday, April 15 at 3:25 p.m.; Level 1, Room 143B

  • McCabe, Cathleen M. “Phaco Energy Profile of Various Nuclear Disassembly Techniques in the Setting of Adaptive Fluidics.” Sunday, April 15 at 3:02 p.m.; Level 1, Room 143B

  • McCabe, Cathleen M. “Intraoperative Evaluation of New Vacuum-Based Phaco System with Adaptive Fluidics.” Sunday, April 15 at 3:45 p.m.; Level 1, Room 143B

  • Packer, Mark. “Comparison of Spectacle Independence for a New Toric Intraocular Lens (IOL) versus Predicate Spherical IOL.” Sunday, April 15 at 8:51 a.m.; Level 1, Room 143A

  • Packer, Mark. “Modeling the Effect of Off-Axis Light for Refractive and Diffractive IOLs.” Sunday, April 15 at 8:45 a.m.; Level 1, Room 143C

  • Shultz, Mitchell C. “Comparative Analysis of Dual Linear Venturi Phacoemulsification Using New Adaptive Fluidics System in Femtosecond-Assisted and Traditional Cataract Surgery.” Sunday, April 15 at 3:07 p.m.; Level 1, Room 143B

  • Shultz, Mitchell C. “Comparative Analysis of Dual Linear Venturi Phacoemulsification with New Adaptive Fluidics System in Traditional Phacoemulsification of Various Nuclear Densities.” Sunday, April 15 at 3:17 p.m.; Level 1, Room 143B


Monday, April 16
  • Jackson, Mitchell A. “Advantages of Multiburst Phaco Modality in Femtosecond Laser-Assisted Cases.” Monday, April 16 at 3:41 p.m.; Level 1, Room 143A

  • Liang, Eva I. “Comparison of Visual Outcomes of a Toric Accommodating IOL and a Toric Extended-Depth-of Focus IOL.” Monday, April 16 at 8:17 a.m.; Level 1, Room 143B

  • Liang, Eva I. “Patient Selection and Comparison of Visual Outcomes of an Accommodating IOL and an Extended-Depth-of-Focus IOL.” Monday, April 16 at 8:43 a.m.; Level 1, Room 143B

  • Sheppard, John. “Twelve-Month Clinical Experience with a Hydrophobic Acrylic IOL in Patients at Risk for Intraocular Inflammation.” Monday, April 16 at 3:12 p.m.; Level 1, Room 143C


Tuesday, April 17
  • Rowen, Sheri L. “Surgical Outcomes for Accommodative Intraocular Lens (IOL) in Patients with Highly Aberrated Corneas.” Tuesday, April 17 at 11:08 a.m.; Level 1, Room 143C

  • Stephenson, Dee. “Clinical Evaluation of a New Material for Hydrophobic Acrylic IOL.” Tuesday, April 17 at 11:03 a.m.; Level 1, Room 144B

  • Whitman, Jeff. “Postoperative Aberration Profile After Implantation of Hinged, Plate-Haptic Accommodating IOL.” Tuesday, April 17 at 10:51 a.m.; Level 1, Room 143C


Posters
  • Lu, Kenneth. “Using Pattern ERG to Objectively Measure Contrast Sensitivity in Pseudophakes with Different IOLs.” Poster available Saturday, April 14 to Tuesday, April 17

  • O’Brien, Terrence P. “Manual versus Femtosecond Corneal Incisions.” Poster available Saturday, April 14 to Tuesday, April 17

  • Singh, Inder. “Topology Verification of Femtosecond-Created Capsulorhexis and Arcuate Incisions Using Intraoperative Guidance System.” Poster available Saturday, April 14 to Tuesday, April 17


Films
  • Shultz, Mitchell C. “Adaptive Fluidics in Femtosecond Laser–Assisted Cataract Surgery.” Film available Saturday, April 14 to Tuesday, April 17


Featured Educational Programs
Bausch + Lomb will support a variety of educational events during the ASCRS meeting, including:

Educational Symposia: “Transitioning to Premium Cataract and Refractive Technology”  
On Sunday, April 15, Bausch + Lomb will host a lively discussion on how to successfully transition practices to offering premium cataract and refractive surgery using several of Bausch + Lomb’s Surgical technologies, which include the enVista® IOL with StableFlex™ technology, Stellaris Elite™ vision enhancement system, and the VICTUS® femtosecond laser.  The event, open to all meeting attendees, will be held at the Walter E. Washington Convention Center in the EyeWorld 2 Theater (Ballroom C, located on the third floor) and led by an impressive and diverse group of speakers; Robert J. Weinstock, M.D., as the moderator, and faculty, Karolinne Rocha, M.D., John Shepherd, M.D., Dee Stephenson, M.D., and Mitch. C. Shultz, M.D. Registration and reception will begin at 4:45 p.m., with the program commencing at 5:15 p.m. Attendees can register online at: http://meetings.eyeworld.org/bausch


Industry Spotlight Theater 
For the second consecutive year, Bausch + Lomb will participate in several of the Industry Spotlight Theater presentations offered by the ASCRS ASOA Symposium & Congress. These educational discussions are designed to provide attendees the opportunity to learn about different ophthalmic products and categories. A distinguished group of speakers will participate in the sessions, several of which will include discussion of technologies from the Bausch + Lomb surgical portfolio. These include:   



Sunday, April 15
  • 9:30 to 10:30 a.m. - the “Femtosecond Laser and other Automated Capsulotomy Technologies” session, featuring the VICTUS® femtosecond laser and speaker, Tom Elmer, M.D.

  • 11 to 12:00 p.m. - the “Devices That Will Help You” session, with speaker, Kevin Blinder, M.D.



Monday, April 16
  • 9:30 to 10:30 a.m. - the “Phacoemulsification Systems for Cataract Surgery, Part I” session, featuring the Stellaris Elite™ and speaker, Zaina Al-Mohtaseb, M.D.

  • 11:50 a.m. to 12:50 p.m. – the “Presbyopia Correction 2018: Where Do We Currently Stand? Part I” session, featuring the Trulign® Toric and Crystalens® AO IOLs and speaker, Binoy Jani, M.D.

  • 1:00 to 2:00 p.m. - the “Phacoemulsification Systems for Cataract Surgery, Part II” session, featuring the Stellaris Elite™ and speaker, Cal Roberts, M.D., chief medical officer, Bausch + Lomb

  • 2:15 to 3:15 p.m. - the “Presbyopia Correction 2018: Where Do We Currently Stand?, Part II” session, featuring Crystalens® AO IOLs and speaker, Cal Roberts, M.D., chief medical officer, Bausch + Lomb

About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Its core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries.

###

®/™ are trademarks of Bausch & Lomb Incorporated or its affiliates. Any other product/brand names are trademarks of the respective owners.
© 2018 Bausch & Lomb Incorporated. 
MTB.0188.USA.18


Print

Number of views (1308)/Comments (0)

x